Breaking News

Sai Life Sciences Opens High-Potency API Manufacturing Facility

Designed and validated to handle high potent molecules less than 1 μg/m3 containment.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sai Life Sciences, one of India’s fastest growing contract research, development and manufacturing organizations (CRO-CDMO), has opened a new high-potency API (HPAPI) manufacturing facility at its cGMP API manufacturing campus in Bidar, India. The addition of this new facility expands the company’s expertise across HPAPI development and manufacturing, providing its customers with a streamlined pathway for NCE development. “In recent years, we have been seeing an increase in projec...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters